Navigation Links
Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
Date:10/27/2008

leted all scheduled doses at week 12, 54 percent of epratuzumab 360mg/m2 patients showed a BILAG response compared with 21 percent of placebo patients. Additionally, epratuzumab treated patients achieved a sustained BILAG response sooner than placebo treated patients.

The study also evaluated the ability of epratuzumab to reduce corticosteroid (CS) use, or "steroid sparing" effects, in patients. At weeks 20-24, 75 percent of epratuzumab 360mg/m2 and 100 percent of epratuzumab 720mg/m2 patients achieved tapering of corticosteroids compared to 57 percent of placebo. Epratuzumab patients used cumulatively less corticosteroids than placebo patients over 24 weeks.

In the HRQoL analysis, there were clinically meaningful improvements over 12-48 weeks with epratuzumab 720 and 36-48 weeks with epratuzumab 360 compared to placebo as assessed by the SF-36, a 36-question short-form health survey assessing physical and mental health, including specific questions for physical function, bodily pain, general health, vitality, social and emotional function, and mental health.

Overall, the most commonly reported AE among all patients was upper respiratory tract infection which was experienced by a higher percentage of patients in the placebo group. Additionally, anemia and fatigue were some of the events reported more frequently in the placebo treated group. Of the remainder of the AEs occurring at greater than or equal to 10% incidence in any treatment arm, the following are some of those reported in a higher percentage of patients treated with either dose of epratuzumab compared to placebo treatment: arthralgia, sinusitis, nausea, pyrexia, abdominal pain, oral candidiasis, peripheral edema, chest pain, pharyngolaryngeal pain, rash, abdominal pain upper, and cough. Serious infections (serious adverse events that were infections) occurred in 18% of epratuzumab-treated, and 22% of placebo-treated patients.

Notes to editors:

About SL0003 and SL0004 '/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Pa. , Jan. 23, 2015  MedScope ( www.medscope.org ... been nominated for a 2015 Connected World ... Emergency Response System (mPERS), that can be used anywhere, ... technology partner.  In nominating MedScope, ...
(Date:1/23/2015)... Fla. and DUBLIN , Jan. ... the agreement with KRS Global Biotechnology, Inc. for the compounding, ... be compounded for shipment in the United States ... FDA approved Outsourcing Facility capable of compounding naltrexone tablets in ...
(Date:1/23/2015)... , Jan. 23, 2015  Pete Rose, baseball,s all-time hits leader, ... arthritis pain reliever Myoflex, Ducere Pharma has announced. ... are excited to have him on board with Myoflex," said ... is a legendary player who is known across all generations. ...
Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4Pete Rose bets on Myoflex to relieve aches and pains 2
(Date:1/23/2015)... (PRWEB) January 23, 2015 Hastings and Hastings, ... matters, reports a record number of legal representation client review ... there has been a steady rise in the number of ... and at home throughout the Valley. With that said, a ... be reviewed by an experienced law firm. Hastings and Hastings ...
(Date:1/22/2015)... with its top dressmaking technologies, has been a leading dress ... its latest designs of wedding dresses and launching a site-wide ... all the fresh new products are designed for 2015, and ... off. All the clothes from LunaDress follow up with the ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, AZ ... Alliance (PPHA). The PPHA's passion for others' well-being and ... greats, treated for obstructive sleep apnea (OSA) has propelled them ... in the valley. The most recent plans for an event ...
(Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
(Date:1/22/2015)... 2015 A new white paper by ... person-centeredness in the long-term care environment as well as ... continuum. The paper, “The Power of Person-Centeredness in Long-Term ... practices of the patient, resident and family experience in ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Reports a Record Number of Client Review Requests for Slip and Fall Accidents in 2014 2Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3
... 2009 -- Children regularly exposed to tobacco smoke at ... adulthood. This finding by researchers at Columbia University,s Mailman ... not recover completely from the effects of early-life exposures ... the December 2009 American Journal of Epidemiology . ...
... ... one percent of the risk of electronic cigarettes and that attacks on them are due ... ... Professor Carl Phillips, associate professor at the University of Alberta, has argued that electronic cigarettes ...
... ... American children overweight and obese, Smart for Life,s new THIN ADVENTURE(TM) ... for children between the ages of 6 and 14. It will be ... , The program was designed by Dr. Sasson Moulavi ( Dr. Sass ...
... , , Site recognized as Best Online Health ... , WESTPORT, Conn. , Dec. 28 dLife, the ... to its Web site dlife.com reached an all time high with ... in which dlife.com metrics rose 35%+ versus 2008 in visits and ...
... effectiveness, but many don,t, study finds , MONDAY, Dec. 28 ... don,t return for follow-up tests that make sure the procedure ... go back, and therefore risk an unwanted pregnancy, are more ... of four or more children, the study found. , The ...
... ... Hailed by best selling authors such as Jack Canfield, Dr. Joe ... after fitness guru to date, who entertains, educates and enlightens audiences worldwide ... Nicole Lee (JNL) is a weight loss success story who has become ...
Cached Medicine News:Health News:Exposure to tobacco smoke in childhood home associated with early emphysema in adulthood 2Health News:Professor: No Doubt Electronic Cigarettes Safer than Cigarettes 2Health News:THIN ADVENTURE(TM) Presents the First Children's Do-It-Yourself Weight-Loss Program 2Health News:THIN ADVENTURE(TM) Presents the First Children's Do-It-Yourself Weight-Loss Program 3Health News:THIN ADVENTURE(TM) Presents the First Children's Do-It-Yourself Weight-Loss Program 4Health News:dLife.com Hits 1 Million Plus Visitors! 2Health News:Half of Men Fail to Check if Vasectomy is Working 2Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 2Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 3Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 4
...
Inquire...
Diamond Reusable Probed work with all ACMI™ instrument inserts. Dual trumpet valves provide smooth, effective fingertip control over suction and irrigation....
Corson Suction-Irrigation Probes are designed to provide flexibility and reliability in a disposable probe....
Medicine Products: